Chapter/Section Purchase

Leave This Empty:

Global Corticosteroid Injections for Joint Pain Market Insights and Forecast to 2028

Choose Chapter/Section to Purchase

List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Corticosteroid Injections for Joint Pain Product Introduction
1.2 Market by Type
1.2.1 Global Corticosteroid Injections for Joint Pain Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Knee & Ankle
1.2.3 Hip Joint
1.2.4 Shoulder & Elbow
1.2.5 Facet Joints of the Spine
1.2.6 Others
1.3 Market by Application
1.3.1 Global Corticosteroid Injections for Joint Pain Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Corticosteroid Injections for Joint Pain Sales Estimates and Forecasts 2017-2028
2.2 Global Corticosteroid Injections for Joint Pain Revenue Estimates and Forecasts 2017-2028
2.3 Global Corticosteroid Injections for Joint Pain Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Corticosteroid Injections for Joint Pain Sales by Region
2.4.1 Global Corticosteroid Injections for Joint Pain Sales by Region (2017-2022)
2.4.2 Global Sales Corticosteroid Injections for Joint Pain by Region (2023-2028)
2.5 Global Corticosteroid Injections for Joint Pain Revenue by Region
2.5.1 Global Corticosteroid Injections for Joint Pain Revenue by Region (2017-2022)
2.5.2 Global Corticosteroid Injections for Joint Pain Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Corticosteroid Injections for Joint Pain Sales by Manufacturers
3.1.1 Global Top Corticosteroid Injections for Joint Pain Manufacturers by Sales (2017-2022)
3.1.2 Global Corticosteroid Injections for Joint Pain Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Corticosteroid Injections for Joint Pain in 2021
3.2 Global Corticosteroid Injections for Joint Pain Revenue by Manufacturers
3.2.1 Global Corticosteroid Injections for Joint Pain Revenue by Manufacturers (2017-2022)
3.2.2 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Corticosteroid Injections for Joint Pain Revenue in 2021
3.3 Global Corticosteroid Injections for Joint Pain Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Corticosteroid Injections for Joint Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Corticosteroid Injections for Joint Pain Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Corticosteroid Injections for Joint Pain Sales by Type
4.1.1 Global Corticosteroid Injections for Joint Pain Historical Sales by Type (2017-2022)
4.1.2 Global Corticosteroid Injections for Joint Pain Forecasted Sales by Type (2023-2028)
4.1.3 Global Corticosteroid Injections for Joint Pain Sales Market Share by Type (2017-2028)
4.2 Global Corticosteroid Injections for Joint Pain Revenue by Type
4.2.1 Global Corticosteroid Injections for Joint Pain Historical Revenue by Type (2017-2022)
4.2.2 Global Corticosteroid Injections for Joint Pain Forecasted Revenue by Type (2023-2028)
4.2.3 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Type (2017-2028)
4.3 Global Corticosteroid Injections for Joint Pain Price by Type
4.3.1 Global Corticosteroid Injections for Joint Pain Price by Type (2017-2022)
4.3.2 Global Corticosteroid Injections for Joint Pain Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Corticosteroid Injections for Joint Pain Sales by Application
5.1.1 Global Corticosteroid Injections for Joint Pain Historical Sales by Application (2017-2022)
5.1.2 Global Corticosteroid Injections for Joint Pain Forecasted Sales by Application (2023-2028)
5.1.3 Global Corticosteroid Injections for Joint Pain Sales Market Share by Application (2017-2028)
5.2 Global Corticosteroid Injections for Joint Pain Revenue by Application
5.2.1 Global Corticosteroid Injections for Joint Pain Historical Revenue by Application (2017-2022)
5.2.2 Global Corticosteroid Injections for Joint Pain Forecasted Revenue by Application (2023-2028)
5.2.3 Global Corticosteroid Injections for Joint Pain Revenue Market Share by Application (2017-2028)
5.3 Global Corticosteroid Injections for Joint Pain Price by Application
5.3.1 Global Corticosteroid Injections for Joint Pain Price by Application (2017-2022)
5.3.2 Global Corticosteroid Injections for Joint Pain Price Forecast by Application (2023-2028)
6 North America
6.1 North America Corticosteroid Injections for Joint Pain Market Size by Type
6.1.1 North America Corticosteroid Injections for Joint Pain Sales by Type (2017-2028)
6.1.2 North America Corticosteroid Injections for Joint Pain Revenue by Type (2017-2028)
6.2 North America Corticosteroid Injections for Joint Pain Market Size by Application
6.2.1 North America Corticosteroid Injections for Joint Pain Sales by Application (2017-2028)
6.2.2 North America Corticosteroid Injections for Joint Pain Revenue by Application (2017-2028)
6.3 North America Corticosteroid Injections for Joint Pain Market Size by Country
6.3.1 North America Corticosteroid Injections for Joint Pain Sales by Country (2017-2028)
6.3.2 North America Corticosteroid Injections for Joint Pain Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Corticosteroid Injections for Joint Pain Market Size by Type
7.1.1 Europe Corticosteroid Injections for Joint Pain Sales by Type (2017-2028)
7.1.2 Europe Corticosteroid Injections for Joint Pain Revenue by Type (2017-2028)
7.2 Europe Corticosteroid Injections for Joint Pain Market Size by Application
7.2.1 Europe Corticosteroid Injections for Joint Pain Sales by Application (2017-2028)
7.2.2 Europe Corticosteroid Injections for Joint Pain Revenue by Application (2017-2028)
7.3 Europe Corticosteroid Injections for Joint Pain Market Size by Country
7.3.1 Europe Corticosteroid Injections for Joint Pain Sales by Country (2017-2028)
7.3.2 Europe Corticosteroid Injections for Joint Pain Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Corticosteroid Injections for Joint Pain Market Size by Type
8.1.1 Asia Pacific Corticosteroid Injections for Joint Pain Sales by Type (2017-2028)
8.1.2 Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Type (2017-2028)
8.2 Asia Pacific Corticosteroid Injections for Joint Pain Market Size by Application
8.2.1 Asia Pacific Corticosteroid Injections for Joint Pain Sales by Application (2017-2028)
8.2.2 Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Application (2017-2028)
8.3 Asia Pacific Corticosteroid Injections for Joint Pain Market Size by Region
8.3.1 Asia Pacific Corticosteroid Injections for Joint Pain Sales by Region (2017-2028)
8.3.2 Asia Pacific Corticosteroid Injections for Joint Pain Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Corticosteroid Injections for Joint Pain Market Size by Type
9.1.1 Latin America Corticosteroid Injections for Joint Pain Sales by Type (2017-2028)
9.1.2 Latin America Corticosteroid Injections for Joint Pain Revenue by Type (2017-2028)
9.2 Latin America Corticosteroid Injections for Joint Pain Market Size by Application
9.2.1 Latin America Corticosteroid Injections for Joint Pain Sales by Application (2017-2028)
9.2.2 Latin America Corticosteroid Injections for Joint Pain Revenue by Application (2017-2028)
9.3 Latin America Corticosteroid Injections for Joint Pain Market Size by Country
9.3.1 Latin America Corticosteroid Injections for Joint Pain Sales by Country (2017-2028)
9.3.2 Latin America Corticosteroid Injections for Joint Pain Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Corticosteroid Injections for Joint Pain Market Size by Type
10.1.1 Middle East and Africa Corticosteroid Injections for Joint Pain Sales by Type (2017-2028)
10.1.2 Middle East and Africa Corticosteroid Injections for Joint Pain Revenue by Type (2017-2028)
10.2 Middle East and Africa Corticosteroid Injections for Joint Pain Market Size by Application
10.2.1 Middle East and Africa Corticosteroid Injections for Joint Pain Sales by Application (2017-2028)
10.2.2 Middle East and Africa Corticosteroid Injections for Joint Pain Revenue by Application (2017-2028)
10.3 Middle East and Africa Corticosteroid Injections for Joint Pain Market Size by Country
10.3.1 Middle East and Africa Corticosteroid Injections for Joint Pain Sales by Country (2017-2028)
10.3.2 Middle East and Africa Corticosteroid Injections for Joint Pain Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Corporation Information
11.1.2 Allergan Overview
11.1.3 Allergan Corticosteroid Injections for Joint Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Allergan Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allergan Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Corticosteroid Injections for Joint Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Corticosteroid Injections for Joint Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Sanofi Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Anika Therapeutics
11.4.1 Anika Therapeutics Corporation Information
11.4.2 Anika Therapeutics Overview
11.4.3 Anika Therapeutics Corticosteroid Injections for Joint Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Anika Therapeutics Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Anika Therapeutics Recent Developments
11.5 Ferring
11.5.1 Ferring Corporation Information
11.5.2 Ferring Overview
11.5.3 Ferring Corticosteroid Injections for Joint Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Ferring Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Ferring Recent Developments
11.6 Bioventus
11.6.1 Bioventus Corporation Information
11.6.2 Bioventus Overview
11.6.3 Bioventus Corticosteroid Injections for Joint Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bioventus Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bioventus Recent Developments
11.7 Flexion Therapeutics
11.7.1 Flexion Therapeutics Corporation Information
11.7.2 Flexion Therapeutics Overview
11.7.3 Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Flexion Therapeutics Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Flexion Therapeutics Recent Developments
11.8 Zimmer Biomet
11.8.1 Zimmer Biomet Corporation Information
11.8.2 Zimmer Biomet Overview
11.8.3 Zimmer Biomet Corticosteroid Injections for Joint Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Zimmer Biomet Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Zimmer Biomet Recent Developments
11.9 SEIKAGAKU
11.9.1 SEIKAGAKU Corporation Information
11.9.2 SEIKAGAKU Overview
11.9.3 SEIKAGAKU Corticosteroid Injections for Joint Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 SEIKAGAKU Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 SEIKAGAKU Recent Developments
11.10 Chugai Pharma
11.10.1 Chugai Pharma Corporation Information
11.10.2 Chugai Pharma Overview
11.10.3 Chugai Pharma Corticosteroid Injections for Joint Pain Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Chugai Pharma Corticosteroid Injections for Joint Pain Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Chugai Pharma Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Corticosteroid Injections for Joint Pain Industry Chain Analysis
12.2 Corticosteroid Injections for Joint Pain Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Corticosteroid Injections for Joint Pain Production Mode & Process
12.4 Corticosteroid Injections for Joint Pain Sales and Marketing
12.4.1 Corticosteroid Injections for Joint Pain Sales Channels
12.4.2 Corticosteroid Injections for Joint Pain Distributors
12.5 Corticosteroid Injections for Joint Pain Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Corticosteroid Injections for Joint Pain Industry Trends
13.2 Corticosteroid Injections for Joint Pain Market Drivers
13.3 Corticosteroid Injections for Joint Pain Market Challenges
13.4 Corticosteroid Injections for Joint Pain Market Restraints
14 Key Findings in The Global Corticosteroid Injections for Joint Pain Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer